Fellowship · Las Vegas, NV
Sponsored by Kirk Kerkorian School of Medicine at UNLV
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Annals of the rheumatic diseases · 2023 · 125 citations · Winn Chatham
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis.
Science translational medicine · 2023 · 96 citations · Heidi Wong
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 163 citations · Winn Chatham
Cytokine Storm Syndrome.
Annual review of medicine · 2023 · 109 citations · Winn Chatham
Methodologies to Isolate and Purify Clinical Grade Extracellular Vesicles for Medical Applications.
Cells · 2022 · 110 citations · Sai Kodam
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 56 citations · Winn Chatham
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.
Annals of the rheumatic diseases · 2024 · 50 citations · Winn Chatham
Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.
The Journal of physiology · 2023 · 56 citations · Sai Kodam